An asthma medication improves asthma control, respiratory quality of life, and upper airway symptoms in patients with chronic rhinosinusitis with nasal polyps.

CEO Barry Quart outlined the company’s focus on rademikibart, an IL-4 receptor alpha monoclonal antibody he described as a “next-generation DUPIXENT,” during a presentation at the Leerink Partners ...

Despite a wealth of available treatments to control the symptoms of chronic asthma, the lung disease has no cure. The discovery of an unexpected cause of asthma could change that. A glitch in the ...

CEO Barry Quart told investors at Oppenheimer’s 36th Annual Healthcare Life Science Conference that the company is advancing its lead asset, rademikibart, into what it described as a novel treatment a ...

UB researchers have been awarded a five-year, $3.2 million grant to study the delivery of comprehensive asthma care to Buffalo Public Schools children with frequent asthma attacks. Funded by the ...

Objective: The effects of passive smoke exposure on respiratory health are still under debate. Therefore, we examined the risk of respiratory symptoms related to passive smoke exposure among German ...

Please provide your email address to receive an email when new articles are posted on . More patients with vs. without asthma reported chronic cough. The likelihood for chronic cough increased among ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified three subtypes of chronic rhinosinusitis and trajectories of asthma and allergy with ...

By Linda Naa Deide AryeeteyCape Town, March 6, GNA – The World Health Organisation (WHO) General Special Envoy on Chronic ...

Chimeric antigen receptor (CAR) T cell therapy has been shown to be hugely advantageous in the treatment of cancers. This therapy employs genetically modified T-cells to find and destroy cancers. Now, ...

Climate change might intensify dust storms, causing more respiratory health risks.